Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Lancet HIV. 2016 Sep 19;3(11):e529–e538. doi: 10.1016/S2352-3018(16)30053-4

Table 2.

CBT-AD compared to ETAU and ISP-AD: Adjusted acute (month 4) outcome scores by study condition, mean and standard error

CBT-AD ETAU Significance level CBT-AD ISP-AD Significance level
CGI 2·60 (0·13) 3·26 (0·18) 0·005 2·60 (0·14) 2·80 (0·13) 0·308
MADRS 17·65 (1·03) 22·33 (1·38) 0·007 18·48 (1·03) 19·04 (1·00) 0·698
CD4 586·86 (19·68) 595·55 (26·45) 0·791 593·73 (21·42) 603·42 (21·21) 0·748
Viral load (log10) 1·99 (0·06) 2·10 (0·08) 0·288 1·98 (0·06) 2·09 (0·06) 0·308
Detectable viral load,
proportion		 0.17 (0.06) 0.17 (0.04) 0·799 0.16 (0.04) 0.20 (0.05) 0·471

Data are mean (SE) for continuous measures and proportion (SE) for binary measures. Scores are adjusted for baseline outcome measures and through the use of ANCOVA (for continuous measures) and logistic regression (for binary measures). CBT-AD=cognitive behavioral therapy for adherence and depression; ETAU=enhanced treatment as usual; ISP-AD=individualized supportive psychotherapy for adherence and depression; CGI=Clinical Global Impression scale; MADRS=Montgomery-Asberger Depression Rating Scale.